Lilly's Loxo Bet Pays Off In Thyroid Cancer, A Second Indication For Selpercatinib

 
• By Mandy Jackson
Thyroid-cancer
Lilly will seek approval in RET-mutant medullary thyroid cancer. • Source: Shutterstock

More from Clinical Trials

More from R&D